Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fractionated Total Body Irradiation (FTBI), Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Allogeneic Bone Marrow Transplantation for Patients With Advanced Leukemia or High Grade Lymphoma

NCT00186290 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00186290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00186290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fractionated Total Body Irradiation (FTBI), Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Allogeneic Bone Marrow Transplantation for Patients With Advanced Leukemia or High Grade Lymphoma
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
December 31, 1989
Completion date
October 31, 2009
Enrollment
145 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood and marrow transplant (bmt), leukemia, lymphoma, non-hodgkin, lymphomas: non-hodgkin